Job Title Sort ascending Business Location Site Date Posted; Višji strokovnjak za področje vizualne kontrole (m/ž/d) / Senior Visual Inspection Expert (m/f/d) Regulär, Full time Innovative Medicines ...

We are excited to welcome the talented team at Regulus to Novartis as we continue to build on our pipeline in renal disease with high unmet medical need.” Farabursen is an investigational ...

Positionsbezeichnung Sort ascending Business Standort Site Erscheinungsdatum; Višji strokovnjak za področje vizualne kontrole (m/ž/d) / Senior Visual Inspection Expert (m/f/d) Regulär, Full time ...

Buscador de empleo. Encuentre oportunidades en Novartis y Sandoz a continuación. Para puestos adicionales con Novartis Gene Therapies (anteriormente AveXis). visite GTx Career Search.. Aviso para los ...

The purpose of this study is to evaluate the effect of two different doses of ianalumab versus placebo in addition to first-line corticosteroids in maintaining platelet count ≥30 G/L in adult ...

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the ...

At Novartis, we reimagine medicine to improve and extend people’s lives. This includes discovering and developing breakthrough therapies, providing quality generics and biosimilars, and finding new ...

Researchers in Biomedical Research work across several diseases areas to uncover insights into the origins and pathogenesis of disease to drive drug discovery and early development, while the ...

Ad hoc announcement pursuant to Art. 53 LR. Phase III PSMAfore trial with Pluvicto TM met the primary endpoint of radiographic progression-free survival (rPFS) in PSMA–positive mCRPC who have been ...

Key Inclusion Criteria: * 18 years and older at time of signing consent * Patients with primary or secondary wAIHA documented by positive direct antiglobulin test specific for anti-IgG or anti-IgA, ...

Acquisition of Kate Therapeutics enhances and strengthens Novartis strategic priorities in gene therapy and neuroscience innovation; Transaction includes enabling technology platforms and therapeutic ...

Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations.